XLV, the Health Care Select Sector SPDR ETF, has seen a sharp reversal in short positioning this week — the rebuild that defined the previous note has unwound almost as fast as it arrived.
The short-side story has flipped. Short interest dropped 10.7% in a single session on August 11 and is now down nearly 13% on the week, falling from around 15.4 million shares to 13.7 million. As a percentage of free float, SI has slipped back to 5.3% — meaningfully lower than the 6.0% level flagged just a week ago. The ORTEX short score has eased to 50.0, off from a recent high near 56 in late July, and is close to the midpoint of its range. This is the opposite of a sustained build; it looks more like a tactical short being taken off into strength.
Borrow conditions confirm the retreat. Cost to borrow has dropped 32% on the week to just 0.38% — its lowest point in the 30-day window and firmly in cheap-to-borrow territory. Availability has loosened to nearly 196%, up from around 172% a week ago, meaning there are roughly two shares available for every one currently borrowed. The 52-week low availability reading was 24%, so the lending market is nowhere near stress. Options positioning is mildly defensive — the put/call ratio of 1.35 is running just above its 20-day average of 1.33, but the z-score of 0.65 places it well within normal range. There is no sign of hedging pressure building in the options market to offset the short cover.
The price action is the simplest explanation for the short exit. XLV has risen 3.6% on the week to $168.01, recovering ground lost earlier in the month. The fund's recent note described a quiet but consistent divergence between rising shorts and a retreating price — that divergence has now closed, with the price recovering and the shorts coming off. Healthcare's defensive characteristics have drawn rotation capital as macro uncertainty persists, with dovish Fed signals and solid pharma and biotech earnings providing the fundamental backdrop for the move. The ETF is now up 4.5% over the past month.
Institutional ownership data, last reported through June 30, shows Managed Account Advisors as the largest holder with 8.6% of shares. JPMorgan trimmed its position slightly in Q1, as did Morgan Stanley and several advisory platforms. The holder base is broad across 441 institutions, which is typical for a large sector ETF used as a tactical allocation tool rather than a conviction long.
The key dynamic to watch now is whether SI stabilises around the 5% level or continues declining toward the 13-million-share floor seen in mid-July. If the ETF holds its recent gains, further short cover would confirm that the July-August build was a tactical macro hedge rather than a structural bearish view on healthcare — and the short score drifting back below 50 would be the clearest signal of that shift.
See the live data behind this article on ORTEX.
Open XLV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
